Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
J&J must pay $260 million in latest talc trial, Oregon jury says
08:37pm, Monday, 03'rd Jun 2024
Johnson & Johnson must pay $260 million in the case of an Oregon woman who said she got mesothelioma from inhaling the company's talc powder, a jury found on Monday.
Three Stock Lunch: Johnson & Johnson, Costco & Spotify
03:01pm, Monday, 03'rd Jun 2024
Gina Sanchez, Lido Advisors chief market strategist, joins 'Power Lunch' to discuss stock plays for three stocks, including Johnson & Johnson, Costco, and Spotify.
J&J-backed Rapport Therapeutics seeks about $637 mln valuation in US IPO
01:14pm, Monday, 03'rd Jun 2024
Rapport Therapeutics is targeting a valuation of about $637 million in its initial public offering in the United States, as the biopharmaceutical company joins a slew of firms looking to list their sh
Johnson & Johnson CEO on talc lawsuits
10:08am, Monday, 03'rd Jun 2024
The Johnson & Johnson CEO discusses the company's plan to pay $6.5 billion to settle nearly all of the thousands of lawsuits in the U.S. claiming its talc-based products caused ovarian cancer. Those c
Johnson & Johnson CEO: Our aim is to become the number one oncology company
09:49am, Monday, 03'rd Jun 2024
CNBC's Angelica Peebles and Johnson & Johnson CEO Joaquin Duato join 'Squawk on the Street' to discuss the company's goals in oncology, the future of cancer treatments, state of the talc lawsuits, dru
7 Overlooked Stocks That Belong in Every Portfolio
06:00am, Monday, 03'rd Jun 2024
The financial media does its best to keep you informed about what's happening in the market. However, this has the effect of giving significant attention to a handful of leaders or laggards.
5 Relatively Secure And Cheap Dividend Stocks To Invest In - June 2024
09:00am, Saturday, 01'st Jun 2024
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering large discounts to their historical norms. We go over our filtering pr
3 Magnificent Dividend Stocks to Buy and Hold Forever
05:50am, Saturday, 01'st Jun 2024
Johnson & Johnson is a Dividend King that's investing heavily in R&D and making smart acquisitions. Target is another Dividend King that continually looks for new ways to boost sales.
Johnson & Johnson: Market Will Regret The Overreaction
11:23am, Friday, 31'st May 2024
Johnson & Johnson stock prices have been consistently declining in the recent 1~2 years. The stock is currently undervalued, with lower P/E ratios compared to the sector median and historical averages
Boring Is Beautiful: 3 Blue-Chip Stocks to Buy and Hold Forever
11:00am, Friday, 31'st May 2024
As someone who has been actively investing for several years, I can tell you that it's natural to be drawn to thrilling investment opportunities promising impressive returns. However, I've learned tha
16 Years As A Dividend Growth Investor: Challenges, Opportunities And A Look Ahead
08:59am, Friday, 31'st May 2024
I started a dividend growth portfolio in 2008 and have seen steady increases in dividends over the years. The portfolio has also delivered sizable total returns. The portfolio is focused on dividend g
Johnson & Johnson Completes Acquisition of Shockwave Medical
08:45am, Friday, 31'st May 2024
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced it has completed its acquisition of Shockwave Medical. Shockwave is now part of Johnson & Johnson and will operate a
Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts
06:51pm, Thursday, 30'th May 2024
Johnson & Johnson (JNJ) closed the most recent trading day at $145.28, moving +0.58% from the previous trading session.
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
02:45pm, Thursday, 30'th May 2024
CNBC will be on the ground at the ASCO annual meeting in Chicago. Meanwhile, Epic released a free tool set to help health systems evaluate AI models.
Calls Of The Day: Eli Lilly, UnitedHealth Group, Abbott Labs and Johnson & Johnson
01:47pm, Thursday, 30'th May 2024
The Investment Committee discuss the latest Calls of the Day.
